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Introduction
Damage Associated Molecular Pattern molecules
(DAMPs) like HMGB1 have been demonstrated to be
involved in pathological processes triggering and perpetu-
ating autoimmune arthritis by attraction and activation of
immune cells. The phagocyte-specific S100 proteins A8
and A9 (Myeloid Related Protein 8 and 14, respectively)
are expressed by monoyctes and granulocytes and can
likewise operate as DAMPs by signalling through TLR4
once released into the extracellular space.
Objectives
S100A8/A9 has initially been identified in context with
rheumatoid arthritis (RA). Generally, the proteins have a
high relevance as inflammatory biomarker in various
arthritic conditions, such as juvenile idiopathic arthritis
(JIA). The proteins’ involvement in triggering or perpe-
tuating pathomechanisms in autoimmune polyarthritis is
albeit discussed controversially. We set out to carefully
re-investigate this task and dissect possible contributions
of S100A8/A9 to arthritis pathogenicity.
Methods
Collagen induced arthritis was induced in C57BL/6 and
S100A9-/- mice, the latter lacking both S100A9 and its
binding partner S100A8 at protein level. Disease pro-
gression was monitored by both clinical score and sero-
logical anti type II collagen (CII) autoantibody levels.
Splenic T cell responses upon CII re-stimulation were
studied in presence or absence of S100 protein priming
of either whole splenocytes or bone marrow derived
macrophages (BMDMs).
Results
S100A9-/- mice were almost completely protected from
collagen induced arthritis (CIA). As observed throughout
all experiments, this is accompanied by a strikingly signifi-
cant decrease in anti type II collagen antibody titers
compared to C57BL/6 wild type animals. Compared to
wt-T cells, splenic S100A9-/- T cells respond poorly to CII
re-stimulation. This phenotype can be partly reversed, if
S100A9-/- splenocytes or macrophages (BMDMs), as the
dominant CII antigen presenting cells, are primed with
either S100A8 or S100A8/A9.
Conclusion
In an autoimmune arthritis mouse model S100A8/A9 can
apparently operate at the interface between innate and
adaptive immunity, possibly by modulating antigen
presentation capacities of macrophages and thus affecting
CD4+ T cell stimulation and downstream autoantibody
production. Beyond their role as inflammatory biomarkers
in arthritis S100A8/A9 can therefore likely trigger and
promote autoimmunity. An active contribution to a
distorted cross-talk between innate and adaptive immune
mechanisms, as potentially in place in poly- or oligoarticu-
lar JIA, can be suggested.




1Pediatric Rheumatology & Immunology, Clinical-Translational Innate
Immunity Research, University Children’s Hospital, Münster, Germany.
2Institute of Immunology, Münster, Germany. 3Center for Interdisciplinary
Clinical Research, University of Münster, Münster, Germany.
1Pediatric Rheumatology & Immunology, Clinical-Translational Innate
Immunity Research, University Children’s Hospital, Münster, Germany
Full list of author information is available at the end of the article
Kessel et al. Pediatric Rheumatology 2013, 11(Suppl 2):P330
http://www.ped-rheum.com/content/11/S2/P330
© 2013 Kessel et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Published: 5 December 2013
doi:10.1186/1546-0096-11-S2-P330
Cite this article as: Kessel et al.: PReS-FINAL-2340: A pathogenic role for
S100A8/A9 in experimental autoimmune arthritis. Pediatric Rheumatology
2013 11(Suppl 2):P330.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kessel et al. Pediatric Rheumatology 2013, 11(Suppl 2):P330
http://www.ped-rheum.com/content/11/S2/P330
Page 2 of 2
